Therapeutic Applications of Nitric Oxide for Malignant Tumor in Animal Models and Human Studies

2010 ◽  
pp. 419-441 ◽  
Author(s):  
Hiroyasu Yasuda ◽  
Kazuhiro Yanagihara ◽  
Katsutoshi Nakayama ◽  
Tadashi Mio ◽  
Takahiko Sasaki ◽  
...  
2021 ◽  
Vol 36 (4) ◽  
pp. 523-543
Author(s):  
Vanessa Trindade Bortoluzzi ◽  
Carlos Severo Dutra Filho ◽  
Clovis Milton Duval Wannmacher

2022 ◽  
pp. 113976
Author(s):  
Aviv D. Mizrahi-Kliger ◽  
Lucia K. Feldmann ◽  
Andrea A. Kuhn ◽  
Hagai Bergman

BioEssays ◽  
2004 ◽  
Vol 26 (2) ◽  
pp. 170-179 ◽  
Author(s):  
Scott M. Williams ◽  
Jonathan L. Haines ◽  
Jason H. Moore

2013 ◽  
pp. 267-278
Author(s):  
Suzanne Hendrich ◽  
Diane F. Birt ◽  
Li Li ◽  
Yinsheng Zhao

Author(s):  
Yan-Wen Zhang ◽  
Yu Yao ◽  
Songyang Liu ◽  
Yufeng Chen ◽  
Shaohong Zhou ◽  
...  

Liquid coacervate microdroplets have been widely explored as membrane-free compartment protocells for cargo delivery in therapeutic applications. In this study, coacervate protocells were developed as gene carriers for transfection of...


2021 ◽  
Author(s):  
Moataz Dowaidar

Mesenchymal stem cells (MSCs) have been a new research focus for cancer treatment. Future cancer sufferers will considerably profit from their use in the future. Tumor-directed migratory and integration capacities of MSCs are exceptional, making them potential carriers for the delivery of anticancer medicines, notably cytokines. Their usage in the clinic has lasted around 10 years. The use of mesenchymal stem cells (MSCs) to create successful cancer treatments has been demonstrated in everything from animal models to human studies.


Nitric Oxide ◽  
2021 ◽  
Author(s):  
Paulina Cieślik ◽  
Leszek Kalinowski ◽  
Joanna M. Wierońska

Sign in / Sign up

Export Citation Format

Share Document